Common use of Drug Testing Clause in Contracts

Drug Testing. The laboratory shall test for only the substances and within the limits for the initial and confirmation test as provided within NIDA standards. The initial test shall use an immunoassay which meets the requirements of the Food and Drug Administration for commercial distribution. The following initial cutoff levels shall be used when screening specimens to determine whether they are negative for these five drugs or classes of drugs: Marijuana metabolites 100 ng/ml Cocaine metabolites 300 ng/ml Opiate metabolites1 300 ng/ml Phencyclidine 25 ng/ml Amphetamines 1,000 ng/ml If initial testing results are negative, testing shall be discontinued, all samples destroyed and records of the testing expunged from the employee's file. Only specimens identified as positive on the initial test shall be confirmed using gas chromatography/mass spectrometry (GC/MS) techniques at the following listed cutoff values. Marijuana metabolites2 15 ng/ml Cocaine metabolites3 150 ng/ml Morphine 300 ng/ml Codeine 300 ng/ml Phencyclidine 25 ng/ml Amphetamine 500 ng/ml Methamphetamine 500 ng/ml If confirmatory testing results are negative all samples shall be destroyed and records of the testing expunged from the employee's file.

Drug Testing. The laboratory shall test for only the substances and within the limits for the initial and confirmation test as provided within NIDA standards. The initial test shall use an immunoassay which meets the requirements of the Food and Drug Administration for commercial distribution. The following initial cutoff levels shall be used when screening specimens to determine whether they are negative for these five drugs or classes of drugs: Marijuana metabolites 100 ng/ml Cocaine metabolites 300 ng/ml Opiate metabolites1 300 ng/ml Phencyclidine 25 ng/ml Amphetamines 1,000 ng/ml If initial testing results are negative, testing shall be discontinued, all samples destroyed and records of the testing expunged from the employee's file. Only specimens identified as positive on the initial test shall be confirmed using gas chromatography/mass spectrometry (GC/MS) techniques at the following listed cutoff values. Marijuana metabolites2 15 ng/ml 1 If immunoassay is specific for free morphine the initial test level is 25 ng/ml. 2 Delta-9-tetrahydrocannabinol-9-carboxylic acid Cocaine metabolites3 150 ng/ml Morphine 300 ng/ml Codeine 300 ng/ml Phencyclidine 25 ng/ml Amphetamine 500 ng/ml Methamphetamine 500 ng/ml If confirmatory testing results are negative all samples shall be destroyed and records of the testing expunged from the employee's file.

Drug Testing. The laboratory shall test for only the substances and within the limits for the initial and confirmation test as provided within NIDA standards. The initial test shall use an immunoassay which meets the requirements of the Food and Drug Administration for commercial distribution. The following initial cutoff levels shall be used when screening specimens to determine whether they are negative for these five drugs or classes of drugs: Marijuana metabolites 100 ng/ml Cocaine metabolites 300 ng/ml Opiate metabolites1 300 ng/ml Phencyclidine 25 ng/ml Amphetamines 1,000 ng/ml If initial testing results are negative, testing shall be discontinued, all samples destroyed and records of the testing expunged from the employee's file. Only specimens identified as positive on the initial test shall be confirmed using gas chromatography/mass spectrometry (GC/MS) techniques at the following listed cutoff values. Marijuana metabolites2 15 ng/ml Cocaine metabolites3 150 ng/ml Morphine 300 ng/ml Codeine 300 ng/ml Phencyclidine 1 If immunoassay is specific for free morphine the initial test level is 25 ng/ml Amphetamine 500 ng/ml Methamphetamine 500 ng/ml ml. 2 Delta-9-tetrahydrocannabinol-9-carboxylic acid 3 Benzoylecgonine If confirmatory testing results are negative all samples shall be destroyed and records of the testing expunged from the employee's file.

Drug Testing. The laboratory shall test for only the substances and within the limits for the initial and confirmation test as provided within NIDA standards. The initial test shall use an immunoassay which meets the requirements of the Food and Drug Administration for commercial distribution. The following initial cutoff levels shall be used when screening specimens to determine whether they are negative for these five drugs or classes of drugs: Marijuana metabolites 100 ng/ml Cocaine metabolites 300 ng/ml Opiate metabolites1 300 ng/ml Phencyclidine 25 ng/ml 1 If immunoassay is specific for free morphine the initial test level is 25 ng/ml. Amphetamines 1,000 ng/ml If initial testing results are negative, testing shall be discontinued, all samples destroyed and records of the testing expunged from the employee's file. Only specimens identified as positive on the initial test shall be confirmed using gas chromatography/mass spectrometry (GC/MS) techniques at the following listed cutoff values. Marijuana metabolites2 15 ng/ml Cocaine metabolites3 150 ng/ml Morphine 300 ng/ml Codeine 300 ng/ml Phencyclidine 25 ng/ml Amphetamine 500 ng/ml Methamphetamine 500 ng/ml If confirmatory testing results are negative all samples shall be destroyed and records of the testing expunged from the employee's file.

Drug Testing. The laboratory shall test for only the substances and within the limits for the initial and confirmation test as provided within NIDA standards. The initial test shall use an immunoassay which meets the requirements of the Food and Drug Administration for commercial distribution. The following initial cutoff levels shall be used when screening specimens to determine whether they are negative for these five drugs or classes of drugs: Marijuana metabolites 100 ng/ml Cocaine metabolites 300 ng/ml Opiate metabolites1 metabolites_ 300 ng/ml Phencyclidine 25 ng/ml Amphetamines 1,000 ng/ml If initial testing results are negative, testing shall be discontinued, all samples destroyed and records of the testing expunged from the employee's ’s file. Only specimens identified as positive on the initial test shall be confirmed using gas chromatography/mass spectrometry (GC/MS) techniques at the following listed cutoff values. : Marijuana metabolites2 metabolites 15 ng/ml Cocaine metabolites3 metabolites 150 ng/ml Opiates Morphine 300 ng/ml Codeine 300 ng/ml Phencyclidine 25 ng/ml Amphetamines Amphetamine 500 ng/ml Methamphetamine 500 ng/ml If confirmatory testing results are negative all samples shall be destroyed and records of the testing expunged from the employee's ’s file.

Drug Testing. The laboratory shall test for only the substances and within the limits for the initial and confirmation test as provided within NIDA standards. The initial test shall use an immunoassay which meets the requirements of the Food and Drug Administration for commercial distribution. The following initial cutoff levels shall be used when screening specimens to determine whether they are negative for these five drugs or classes of drugs: Marijuana metabolites 100 ng/ml Cocaine metabolites 300 ng/ml Opiate metabolites1 300 ng/ml Phencyclidine 25 ng/ml Amphetamines 1,000 ng/ml If initial testing results are negative, testing shall be discontinued, all samples destroyed and records of the testing expunged from the employee's file. Only specimens identified as positive on the initial test shall be confirmed using gas chromatography/mass spectrometry (GC/MS) techniques at the following listed cutoff values. Marijuana metabolites2 15 ng/ml Cocaine metabolites3 150 ng/ml Morphine 300 ng/ml Codeine 300 ng/ml Phencyclidine 1 If immunoassay is specific for free morphine the initial test level is 25 ng/ml Amphetamine 500 ng/ml ml. 2 Delta-9-tetrahydrocannabinol-9-carboxylic acid 3 Benzoylecgonine Methamphetamine 500 ng/ml If confirmatory testing results are negative all samples shall be destroyed and records of the testing expunged from the employee's file.

Drug Testing. The laboratory shall test for only the substances and within the limits for the initial and confirmation test as provided within NIDA standards. The initial test shall use an immunoassay which meets the requirements of the Food and Drug Administration for commercial distribution. The following initial cutoff levels shall be used when screening specimens to determine whether they are negative for these five drugs or classes of drugs: Marijuana metabolites 100 ng/ml Cocaine metabolites 300 ng/ml Opiate metabolites1 300 ng/ml Phencyclidine 25 ng/ml Amphetamines 1,000 ng/ml If initial testing results are negative, testing shall be discontinued, all samples destroyed and records of the testing expunged from the employee's file. Only specimens identified as positive on the initial test shall be confirmed using gas chromatography/mass spectrometry (GC/MS) techniques at the following listed cutoff values. Marijuana metabolites2 15 ng/ml Cocaine metabolites3 150 ng/ml Morphine 300 ng/ml Draft Codeine 300 ng/ml Phencyclidine 25 ng/ml Amphetamine 500 ng/ml Methamphetamine 500 ng/ml If confirmatory testing results are negative all samples shall be destroyed and records of the testing expunged from the employee's file.

Drug Testing. The laboratory shall test for only the substances and within the limits for the initial and confirmation test tests as provided within NIDA standardsstandards established by the National Institute of Drug Abuse. The initial test shall use an immunoassay which meets the requirements of the Food and Drug Administration for commercial distribution. The following initial cutoff levels cut-off level shall be used when screening specimens to determine whether they are negative for these five (5) drugs or classes of drugs: Marijuana metabolites 100 ngMetabolites 50 mg/ml Cocaine metabolites Metabolites 300 ngmg/ml Opiate metabolites1 300 ngMetabolites 2000 mg/ml ml1 Phencyclidine 25 ngmg/ml Amphetamines 1,000 ng1000 mg/ml If initial testing results are negative, testing shall be discontinued, all samples destroyed and records of the testing expunged from the employee's ’s file. Only specimens identified as positive on the initial test shall be confirmed using gas chromatography/mass spectrometry (GC/MSM.S.) techniques at the following listed cutoff cut-off values. Marijuana metabolites2 Metabolites2 15 ngmg/ml Cocaine metabolites3 150 ngMetabolites3 300 mg/ml Opiate Morphine 300 ngmg/ml Codeine 300 ngmg/ml Phencyclidine 25 ngmg/ml Amphetamines Amphetamine 500 ngmg/ml Methamphetamine 500 ngmg/ml If confirmatory testing results are negative negative, all samples shall be destroyed and records of the testing expunged from the employee's ’s file. 1If Immunoassay is specific for free morphine, the initial test level is 25 mg/ml. 2Delta - 9 Tetrahydrocannabinaol - carboxylic acid.

Drug Testing. The laboratory shall test for only the substances and within the limits for the initial and confirmation test as provided within NIDA standards. The initial test shall use an immunoassay which meets the requirements of the Food and Drug Administration for commercial distribution. The following initial cutoff levels shall be used when screening specimens to determine whether they are negative for these five drugs or classes of drugs: Marijuana metabolites 100 ng/ml Cocaine metabolites 300 ng/ml Opiate metabolites1 300 ng/ml Phencyclidine 25 ng/ml 1 If immunoassay is specific for free morphine the initial test level is 25 ng/ml. Amphetamines 1,000 ng/ml If initial testing results are negative, testing shall be discontinued, all samples destroyed and records of the testing expunged from the employee's file. Only specimens identified as positive on the initial test shall be confirmed using gas chromatography/mass spectrometry (GC/MS) techniques at the following listed cutoff values. Marijuana metabolites2 15 ng/ml Cocaine metabolites3 150 ng/ml Opiates Morphine 300 ng/ml Codeine 300 ng/ml Phencyclidine 25 ng/ml Amphetamine 500 ng/ml Methamphetamine 500 ng/ml If confirmatory testing results are negative all samples shall be destroyed and records of the testing expunged from the employee's file.